Medical AI software to detect cancer earlier & predict treatment responses
Lunit is a publicly traded company dedicated to developing cutting-edge medical AI software that aids in the fight against cancer. Given that early detection is often crucial for cancer survival, Lunit’s AI-powered cancer screening solutions assist doctors in identifying cancer at an early stage. With a remarkable 97-99% accuracy rate, Lunit INSIGHT can detect abnormal results from chest x-rays that might otherwise go unnoticed by human physicians. Lunit’s SCOPE technology uses AI to predict a patient’s treatment response, enabling doctors to make well-informed decisions about the most effective course of treatment.